Advances in the understanding of B-cell dysregulation in IgA nephropathy (IgAN) are reshaping the therapeutic landscape and creating new opportunities to target key drivers of disease.Join leading experts for an engaging exploration of the B-cell related pathways underlying IgAN pathogenesis and the expanding clinical evidence for new and emerging B-cell directed agents. A dynamic animation will bring the mechanisms of these targeted agents to life and illustrate the roles of key signaling pathways, including APRIL and BAFF. Expert insights into the latest guideline recommendations will further support you in applying emerging evidence to individualized treatment decisions for your patients with IgAN.The program will conclude with a live "Ask the Expert" Q&A session, where you can engage directly with IgAN thought leaders and refine your approach to individualized care.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 414 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Live
- Credit · Up to 1 credit
- Commercial Support
-
WhenNov 18–19, 2026
-
PRIME Education, Inc. (PRIME®) Ushering in a New Era of IgAN Care: Targeted Therapies and Evolving Guidelines
-
PRIME Education, Inc. (PRIME®) New and Emerging Therapies in IgA Nephropathy: Latest Data and Clinical Implications
-
PRIME Education, Inc. (PRIME®) Navigating New Guidelines in IgA Nephropathy
